(Q28288573)

1

0 references

Katharina Modes

3

0 references

Ina Poser

4

0 references

Marion Schuierer

5

0 references

Wolfgang Dietmaier

6

0 references

Petra Ruemmele

7

0 references

Marcus Mühlbauer

8

0 references

Susanne Wallner

9

0 references

Claus Hellerbrand

10

0 references

Anja-Katrin Bosserhoff

Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21

11

0 references

language of work or name

English

0 references

publication date

January 2005

0 references

published in

Laboratory Investigation

0 references

volume

85

0 references

issue

1

0 references

page(s)

124-36

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Cytokine regulation of epithelial permeability and ion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Production of inflammatory cytokines in the intestinal lamina propria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and beta-1,3-D-glucan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

MTAP gene deletion in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

7 January 2021

Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

7 January 2021

Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

7 January 2021

Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

7 January 2021

Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700192

7 January 2021